Objective: Recanalization of the saphenous vein trunk after endovenous radiofrequency ablation (RFA) is often associated with recurrent varicose veins (RVVs) or recanalization. This study aimed to assess the long-term results of RFA of the great saphenous vein (GSV) and identify the risk factors for GSV recanalization and RVVs during follow-up for patients presenting to dedicated outpatient vein centers.

Methods: All consecutive patients with incompetent GSVs who underwent RFA between 2009 and 2019 were retrospectively analyzed. The primary study end points were freedom from GSV recanalization and the RVV rate during follow-up. The secondary study end points were the postoperative complication rate and the risk factors for GSV recanalization and RVVs. Univariate and multivariate analyses were performed to identify the potential risk factors for GSV recanalization and RVVs.

Results: During the study period, 1568 limbs were treated in 1300 consecutive patients (mean age, 53.5 ± 12.9 years; 71.9% women; CEAP [clinical, etiology, anatomy, pathophysiology] C2-C6; venous clinical severity score >5). Technical success was achieved in 99.7% of cases. At a mean follow-up of 57.2 ± 25.4 months, the GSV occlusion and freedom from reintervention rates were 100% and 100% within 1 week, 97% and 95.7% at 1 year, 95.2% and 93.1% at 3 years, and 92.4% and 92.8% at 5 years, respectively. The recurrence rate was 10% (n = 158) during the follow-up period. On multivariate analysis, a direct confluence of the accessory saphenous vein into the saphenofemoral junction (odds ratio [OR], 1.561; 95% confidence interval [CI], 1.0-7.04; P = .032), a history of pregnancy >2 (OR, 3.68; 95% CI, 1.19-11.36; P = .023), C4 (OR, 6.41; 95% CI, 1.36-30.28; P = .019), and preoperative GSV diameter >10 mm (OR, 1.82; 95% CI, 1.65-4.03; P = .043) were risk factors for GSV recanalization. Moreover, age >70 years (OR, 1.04; 95% CI, 1.01-1.06; P = .014) and incompetent perforator veins (OR, 1.17; 95% CI, 0.65-2.03; P = .018) were also risk factors for RVVs.

Conclusions: RFA is a safe technique to ablate the GSV with a low complication rate and durability during 5 years of follow-up. However, patients with a high clinical score and those with direct confluence of the accessory saphenous vein into the saphenofemoral junction experienced higher long-term GSV recanalization and RVV rates.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523386PMC
http://dx.doi.org/10.1016/j.jvsv.2023.08.014DOI Listing

Publication Analysis

Top Keywords

gsv recanalization
24
risk factors
20
saphenous vein
16
factors gsv
16
gsv
10
recurrent varicose
8
recanalization
8
recanalization rvvs
8
follow-up patients
8
consecutive patients
8

Similar Publications

Background: to compare different anesthesia protocols during High Intensity Focused Ultrasound (HIFU) for saphenous trunk (GSV/SSV) and/or varicosities incompetence treatment.

Material And Methods: patients with GSV/SSV incompetence with varicose veins underwent HIFU under different anesthesia protocols. The primary endpoint was the pain score during HIFU using a 10-point scale.

View Article and Find Full Text PDF

Long-term outcomes of mechanochemical ablation using the Clarivein device for the treatment of great saphenous vein incompetence.

J Vasc Surg Venous Lymphat Disord

January 2025

Department of Surgery, Northwest Clinics, Alkmaar, The Netherlands; Department of Surgery, Red Cross Hospital, Beverwijk, The Netherlands.

Objective: The short-term anatomical success rates of mechanochemical ablation using the Clarivein device (Merit Medical) in the treatment of great saphenous vein (GSV) incompetence are high. However, the anatomical success rates seem to drop over time. The aim of this study was to determine the long-term outcomes of GSV treatment using the Clarivein and to assess whether specific anatomical features better correlate with clinical or quality of life (QoL)-related outcomes.

View Article and Find Full Text PDF

Mechanical occlusion chemically assisted ablation (MOCA) of incompetent saphenous veins has been utilized since its FDA approval in 2008. However, only recently have longer-term three and 5 year clinical follow up data become available. This updated information necessitates a societal update to guide treatment and ensure optimal patient outcomes.

View Article and Find Full Text PDF

Vein diameter, obesity, and rates of recanalization after mechanochemical ablation.

J Vasc Surg Venous Lymphat Disord

November 2024

Division of Vascular Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, GA. Electronic address:

Objective: A large vein diameter is associated with higher recanalization rates after endovenous thermal ablation procedures of the great saphenous vein (GSV) and small saphenous vein (SSV). However, relatively few studies have explored the relationship between vein diameter and recanalization rates after mechanochemical ablation (MOCA).

Methods: We conducted a retrospective review of patients with chronic venous insufficiency who underwent MOCA of the GSV or SSV from 2017 to 2021 at a single hospital.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to compare the effectiveness of endovenous microwave ablation (EMA) versus endovenous laser ablation (EVLA), both combined with high ligation, foam sclerotherapy, and compression therapy (HL-FS-CT) for treating venous leg ulcers (VLUs).
  • - A total of 301 patients treated from 2013 to 2022 were analyzed, with 134 receiving EMA and 167 receiving EVLA. The average healing times were 1.45 months for EMA and 1.86 months for EVLA, showing no significant differences in ulcer healing times or complications between the two methods.
  • - Both treatment combinations proved effective for ulcer healing, but the study concluded that
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!